American Century Companies’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25M Buy
355,806
+226,718
+176% +$725K ﹤0.01% 2265
2025
Q4
$352K Buy
129,088
+100,624
+354% +$233K ﹤0.01% 2602
2025
Q3
$61.8K Buy
28,464
+11,528
+68% +$27.2K ﹤0.01% 2763
2025
Q2
$29.1K Sell
16,936
-8,038
-32% -$20K ﹤0.01% 2843
2025
Q1
$83.2K Sell
24,974
-101,680
-80% -$524K ﹤0.01% 2836
2024
Q4
$937K Sell
126,654
-72,020
-36% -$668K ﹤0.01% 2278
2024
Q3
$1.87M Sell
198,674
-4,364
-2% -$41.3K ﹤0.01% 1988
2024
Q2
$1.63M Sell
203,038
-135,478
-40% -$1.45M ﹤0.01% 1982
2024
Q1
$5.02M Buy
338,516
+5,380
+2% +$62.6K ﹤0.01% 1450
2023
Q4
$2.71M Sell
333,136
-75,622
-19% -$396K ﹤0.01% 1645
2023
Q3
$1.86M Sell
408,758
-8,407
-2% -$54.9K ﹤0.01% 1725
2023
Q2
$2.94M Buy
417,165
+97,855
+31% +$700K ﹤0.01% 1509
2023
Q1
$1.95M Buy
319,310
+1,649
+0.5% +$11.4K ﹤0.01% 1618
2022
Q4
$2.03M Sell
317,661
-152,927
-32% -$1.19M ﹤0.01% 1543
2022
Q3
$4.51M Buy
470,588
+5,504
+1% +$63.5K ﹤0.01% 1154
2022
Q2
$5.13M Buy
465,084
+56,194
+14% +$736K ﹤0.01% 1110
2022
Q1
$6.81M Buy
408,890
+357
+0.1% +$5.52K ﹤0.01% 1023
2021
Q4
$7.8M Buy
408,533
+31,379
+8% +$691K ﹤0.01% 948
2021
Q3
$9.3M Buy
377,154
+65
+0% +$1.53K 0.01% 863
2021
Q2
$9.81M Buy
377,089
+7,560
+2% +$197K 0.01% 819
2021
Q1
$11.7M Buy
369,529
+24,141
+7% +$1M 0.01% 749
2020
Q4
$16M Buy
345,388
+218,004
+171% +$8.66M 0.01% 670
2020
Q3
$4.19M Sell
127,384
-31,232
-20% -$957K ﹤0.01% 825
2020
Q2
$4.35M Sell
158,616
-156,340
-50% -$5.14M ﹤0.01% 788
2020
Q1
$9.43M Buy
314,956
+16,912
+6% +$448K 0.01% 615
2019
Q4
$8.25M Buy
298,044
+103,500
+53% +$2.35M 0.01% 726
2019
Q3
$3.54M Buy
+194,544
New +$4.3M ﹤0.01% 877

Other funds holding IOVA